Cases
Bayer Intellectual Property GmbH et al v. Indoco Remedies Limited et al
as 1:2023cv00690
Plaintiff: Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG and others
Defendant: Indoco Remedies Limited and FPP Holding Company LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court: Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teijin Limited et al v. Indoco Remedies Limited
as 1:2017cv00809
Plaintiff: Teijin Limited , Teijin Pharma Limited and Takeda Pharmaceuticals U.S.A., Inc.
Defendant: Indoco Remedies Limited
Cause Of Action: 35 U.S.C. § 145
OTSUKA PHARMACEUTICAL CO., LTD. v. INDOCO REMEDIES LIMITED et al
as 1:2016cv08085
Plaintiff: OTSUKA PHARMACEUTICAL CO., LTD.
Defendant: INDOCO REMEDIES LIMITED and HETERO LABS LIMITED
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. INDOCO REMEDIES LIMITED et al
as 1:2016cv00086
Plaintiff: OTSUKA PHARMACEUTICAL CO., LTD.
Defendant: INDOCO REMEDIES LIMITED and HETERO LABS LIMITED
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. INDOCO REMEDIES LIMITED et al
as 1:2015cv01967
Plaintiff: OTSUKA PHARMACEUTICAL CO., LTD.
Defendant: INDOCO REMEDIES LIMITED and HETERO LABS LIMITED
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?